Matching slides 110,355
Current window 66,181-66,210
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all

Component

66,181-66,210 of 110,355

filter-aware
11
The slide illustrates the biological pathway involving Agrin, LRP4, MuSK, Dok7, and Rapsyn at the neuromuscular junction.argenx SE | Results Presentation Deck | 19 slides · argenx
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
14
The table shows a significant increase in R&D and SG&A expenses leading to a larger net loss compared to the previous year.argenx SE | Results Presentation Deck | 19 slides · argenx
Conference presentation Investor relations Beat · Action1 hit
06
The slide uses a bulleted list with colored circular icons as a visual anchor for each point.Asos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations Beat · Key Takeaways1 hit
07
The slide uses a mix of a data table and bulleted callouts to explain the drivers behind the KPI changes.Asos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations 1 hit
08
The slide uses a combination of qualitative commentary icons and a quantitative data table.Asos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations 1 hit
09
The chart uses a waterfall bridge to explain the 180bps decline.Asos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations 1 hit
11
The chart highlights significant outflows in working capital, tech, and supply chain investments.Asos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations 1 hit
13
The slide uses a bar chart to demonstrate a 20% CAGR and pairs it with three brand identity pillars.Asos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations Beat · Key Messages1 hit
27
Asos | Results Presentation Deck | 27 slidesAsos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations 1 hit
02
Includes a specific date note at the bottom: September 9th, 2022.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
03
The slide uses a numbered list to present five key pillars of the company's current status.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
05
The slide uses a hierarchical structure to connect a high-level objective to three distinct operational pillars.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations Beat · Solution1 hit
06
The slide uses a Gantt-style visualization to represent clinical trial progress for multiple drug candidates.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
07
The slide uses a hub-and-spoke diagram to represent the platform model.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
09
ATAI | Investor Presentation Deck | 36 slidesATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations Loop · Why Now1 hit
11
The slide uses a split layout: left side defines the condition and market size, right side outlines the 'Urgent Need for Innovation' using a process-like list of pain points.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
12
Includes clinical trial data visualization and product summary table.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
13
The slide uses a dark sidebar for product specs and a white main area for clinical data visualization.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
14
The slide uses a split-layout with a dark sidebar for key facts and a white main area for clinical data visualization.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
16
The chart uses a dot plot to show individual patient CADSS scores over time across three cohorts (30mg, 60mg, Placebo).ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
17
The slide uses a timeline diagram to illustrate the clinical trial flow and two boxes to detail study design and operational status.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
18
The slide uses a matrix-style comparison table to highlight competitive advantages.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
20
The slide uses a split-layout: left side defines the condition and global burden, right side details the 'huge need for development' using a vertical timeline-like list.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
22
Includes a quote from Keith Nuechterlein and a detailed clinical trial timeline.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
23
The slide highlights efficacy in cognitive endpoints for a specific patient population (DPNP).ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
27
The slide uses a split-layout: left side provides market context and statistics, right side outlines the 'unaddressed need' framework.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations Beat · Market Sizing1 hit
28
Includes a sidebar summary and a clinical trial design overview.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
29
The slide uses a checkmark matrix to highlight the competitive advantage of the company's drug candidate.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
31
Uses a combination of a map, metric callouts, and a vertical process-style list to convey urgency.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
33
The table highlights DMX-1002's unique profile compared to withdrawal support and maintenance therapies.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit